Journal of Jilin University(Medicine Edition) ›› 2018, Vol. 44 ›› Issue (06): 1243-1248.doi: 10.13481/j.1671-587x.20180623
Previous Articles Next Articles
QI Bingxue, SUN Yadong
Received:2018-04-25
Online:2018-11-28
Published:2018-11-28
CLC Number:
QI Bingxue, SUN Yadong. A prospective study on primary prevention of major vascular lesions of type 2 diabetes mellitus patients in Han population in Northeast China[J].Journal of Jilin University(Medicine Edition), 2018, 44(06): 1243-1248.
| [1] American Diabetes A. (8) cardiovascular disease and risk management[J].Diabetes Care, 2015,38(SupplS):49-57. [2] Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis[J]. JAMA, 2010,304(12):1350-1357. [3] Stam-Slob MC, van der Graaf Y, de Borst GJ, et al. Effect of type 2 diabetes on recurrent major cardiovascular events for patients with symptomatic vascular disease at different locations[J]. Diabetes Care, 2015,38(8):1528-1535. [4] Diabetes control and complications trial (dcct). Update. Dcct research group[J]. Diabetes Care, 1990,13(4):427-433. [5] UK Prospective Diabetes Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33)[J]. Lancet, 1998,352(9131):837-853. [6] Zoungas S, Arima H, Gerstein HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes:A meta-analysis of individual participant data from randomised controlled trials[J]. Lancet Diabet Endocrinol, 2017,5(6):431-437. [7] Zoungas S, Chalmers J, Neal B, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes[J]. New England J Med, 2014,371(15):1392-1406. [8] Agrawal L, Azad N, Bahn GD, et al. Long-term follow-up of intensive glycaemic control on renal outcomes in the veterans affairs diabetes trial (vadt)[J]. Diabetologia, 2018,61(2):295-299. [9] Khunti K, Kosiborod M, Ray KK. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease:Time to overcome multifactorial therapeutic inertia?[J]. Diabet Obesity Metabol, 2018. [10] Control G, Turnbull FM, Abraira C, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes[J]. Diabetologia, 2009,52(11):2288-2298. [11] Paul SK, Klein K, Maggs D, et al. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes:A retrospective observational study[J]. Cardiovasc Diabetol, 2015,14(10). [12] Kostis WJ, Thijs L, Richart T, et al. Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications[J]. Hypertension, 2010,56(6):1060-1068. [13] Kostis WJ, Moreyra AE, Cheng JQ, et al. Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy[J]. J Clin Lipidol, 2011,5(2):97-104. [14] Sever PS, Chang CL, Gupta AK, et al. The anglo-scandinavian cardiac outcomes trial:11-year mortality follow-up of the lipid-lowering arm in the UK[J]. European Heart J, 2011,32(20):2525-2532. [15] Ford I, Murray H, McCowan C, et al. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy:20-year follow-up of west of scotland coronary prevention study[J]. Circulation, 2016,133(11):1073-1080. [16] Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes[J]. New Engl J Med, 2003,348(5):383-393. [17] Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes[J]. New Engl J Med, 2008,358(6):580-591. [18] Gaede P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria:21 years follow-up on the steno-2 randomised trial[J]. Diabetologia, 2016,59(11):2298-2307. [19] Reddy MA, Zhang E, Natarajan R. Epigenetic mechanisms in diabetic complications and metabolic memory[J]. Diabetologia, 2015,58(3):443-455. [20] Volpe M, Cosentino F, Tocci G, et al. Antihypertensive therapy in diabetes:The legacy effect and raas blockade[J]. Current Hypertens Rep, 2011,13(4):318-324. [21] Zhang L, Chen B, Tang L. Metabolic memory:Mechanisms and implications for diabetic retinopathy[J]. Diabet Res Clin Pract, 2012,96(3):286-293. [22] 花琦琦,刘新凤,焦青,等.基于SQL Server的糖尿病信息管理与分析系统[J].中国医学物理学杂志,2016,33(11):1183-1188. |
| [1] | Jing YU,Yinzhuo HUANG,Zhongwei ZHOU,Yuxin XIE,Qian MAO. Analysis on influencing factors in type 2 diabetes mellitus patients complicated with lower limb atherosclerosis and construction of nomogram model [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 806-812. |
| [2] | Shu LI,Jiaqi GUO,Wansong LI,Yanfeng ZHEN,Hongjia ZHAI,Jie LI,Hui FANG. Improvement effect of fingolimod on hepatic fibrosis in type 2 diabetes mellitus mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 330-339. |
| [3] | Jiaxin WANG,Zhenqi WANG,Xuan ZHANG. Expressions of CDKAL1 gene and its splice isomers in peripheral blood lymphocytes of patients with type 2 diabetes mellitus and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1290-1295. |
| [4] | Jing GUAN,Shen HA,Hao YUAN,Ying CHEN,Pengju LIU,Zhi LIU,Shuang JIANG. Protective effect of Modified Xiao-Xian-Xiong Decoction on liver injury in rats with type 2 diabete mellitus and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 608-616. |
| [5] | Xiaowei HUANG,Siqi ZHANG,Yixin ZHANG,Bo LIU,Xin WANG,Fenglan JI,Runze YANG,Huibo XU,Tao DING. Relationship between syndrome manifestations and differentially expressed genes in rat model of type 2 diabetes mellitus with Qi and Yin deficiency explored through transcriptomics [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 625-633. |
| [6] | Junxiong ZHAO,Qian WU,Liangui NIE,Shengquan LIU,Zhentao JIANG,Jian CHEN,Ting XIAO,Jun YANG. Ameliorative effect of SO2 on myocardial fibrosis in type 2 diabetes mellitus rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(1): 8-14. |
| [7] | Yongxin ZHAI,Huaifeng TA,Yi ZHANG,Qijia SUN,Ming ZHANG,Shuqiang FENG,Ranwei LI. Effect of preoperative glycemic level on infection-related complications of diabetic patients after flexible ureteroscopic lithotripsy [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 766-772. |
| [8] | LIU Donghui, FU Wenliang, FU Xiumei, SONG Chengjun, CHEN Zhihong. Regulatory effect of sericin on liver insulin PI3K/Akt signaling pathway in rats of type 2 diabetes mellitus and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 228-232. |
| [9] | QI Lu, BAI Wei, YU Weiying, LI Yuanyuan, HUA Wanqing, KOU Changgui. Randomized controlled trials for curative effect of saxagliptin combined with insulin in treatment of patients with type 2 diabetes mellitus: Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1235-1242. |
| [10] | SUN Zhumei, LIANG Weishi, KANG Jiali, MENG Xubing, WANG Jianxing, HAN Shuying. Dynamic pathological characteristics of kidney in db/db mice with type 2 diabetes mellitus [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 499-503. |
| [11] | LIU Xiaojie, MEI Tao, MA Hongyan, YE Shandong. Analysis of influencing factors of carotid atherosclerosis plaque formation and stability in simple type 2 diabetic patients [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 350-355. |
| [12] | LI Chunhua, GUO Xin, DOU Jing, DING Mingxuan, YAO Yan, ZHANG Yanqiu. Survey analysis on cognitive dysfunction in patients with type 2 diabetes mellitus and its influecing factors [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 431-437. |
| [13] | WANG Jianxing, JIANG Yan, WANG Yan, WU Lei, MU Yu, HAN Shuying. Influence of extract from fermented buckwheat flower and leaf in kidney injury in type 2 diabetic db/db mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 95-100. |
| [14] | GOU Xiangbo, GUO Jing, BAI Jing. Protective effect of total flavones of buckwheat flowers and leaves on myocardial fibrosis of type 2 diabetic ratsand its mechanism [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 694-698. |
| [15] | TU Peipei, LI Xiaodan, MA Baicheng, ZHANG Yaofang, DUAN Huikun, NI Zaizhong, WANG Haisong, JIANG Pingzhe, LI Miao, WU Ri, LI Minggang. Changes and significance of hepatic histone H3 epigenetic modification in type 2 diabetic mice [J]. Journal of Jilin University Medicine Edition, 2015, 41(04): 756-762. |